Diversity of the Escherichia coli Type 1 Fimbrial Lectin

Type 1 fimbriae are the most common adhesive organelles of Escherichia coli. Because of their virtual ubiquity, previous epidemiological studies have not found a correlation between the presence of type 1 fimbriae and urinary tract infections (UTIs). Recently it has become clear that type 1 fimbriae exhibit several different phenotypes, due to allelic variation of the gene for the lectin subunit, FimH, and that these phenotypes are differentially distributed among fecal and UTI isolates. In this study, we have analyzed in more detail the ability of isogenic, recombinant strains ofE. coli expressing fimH genes of the predominant fecal and UTI phenotypes to adhere to glycoproteins and to uroepithelial cells. Evidence was obtained to indicate that type 1 fimbriae differ in their ability to recognize various mannosides, utilizing at least two different mechanisms. All FimH subunits studied to date are capable of mediating adhesion via trimannosyl residues, but only certain variants are capable of mediating high levels of adhesion via monomannosyl residues. The ability of the FimH lectins to interact with monomannosyl residues strongly correlates with their ability to mediate E. coli adhesion to uroepithelial cells. In this way, it would be possible for certain phenotypic variants of type 1 fimbriae to contribute more than others to virulence of E. coli in the urinary tract.

[1]  T. Sun,et al.  In vitro binding of type 1-fimbriated Escherichia coli to uroplakins Ia and Ib: relation to urinary tract infections. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[2]  C. Svanborg,et al.  Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[3]  F. Scannapieco,et al.  Role of Type 1 Fimbriae in the Adhesion of Escherichia coli to Salivary Mucin and Secretory Immunoglobulin A , 1996, Current Microbiology.

[4]  S. Teraguchi,et al.  Glycans of bovine lactoferrin function as receptors for the type 1 fimbrial lectin of Escherichia coli , 1996, Infection and immunity.

[5]  A. Siitonen,et al.  Quantitative differences in adhesiveness of type 1 fimbriated Escherichia coli due to structural differences in fimH genes , 1995, Journal of bacteriology.

[6]  R. O'neill,et al.  A detailed structural characterization of ribonuclease B oligosaccharides by 1H NMR spectroscopy and mass spectrometry. , 1994, Carbohydrate research.

[7]  P. Klemm.  Fimbriae Adhesion, Genetics, Biogenesis, and Vaccines , 1994 .

[8]  E. Sokurenko,et al.  FimH family of type 1 fimbrial adhesins: functional heterogeneity due to minor sequence variations among fimH genes , 1994, Journal of bacteriology.

[9]  E. Sokurenko,et al.  Functional heterogeneity of type 1 fimbriae of Escherichia coli , 1992, Infection and immunity.

[10]  C. Bloch,et al.  A key role for type 1 pili in enterobacterial communicability , 1992, Molecular microbiology.

[11]  C. Gahmberg,et al.  Identification of the leukocyte adhesion molecules CD11 and CD18 as receptors for type 1-fimbriated (mannose-specific) Escherichia coli , 1991, Infection and immunity.

[12]  M. S. McClain,et al.  Type 1 fimbriae mutants of Escherichia coli K12: characterization of recognized afimbriate strains and construction of new fim deletion mutants , 1991, Molecular microbiology.

[13]  H. Courtney,et al.  Aggregation of group A streptococci by human saliva and effect of saliva on streptococcal adherence to host cells , 1991, Infection and immunity.

[14]  J. R. Johnson,et al.  Virulence factors in Escherichia coli urinary tract infection , 1991, Clinical Microbiology Reviews.

[15]  J. Mestecky,et al.  Secretory immunoglobulin A carries oligosaccharide receptors for Escherichia coli type 1 fimbrial lectin , 1990, Infection and immunity.

[16]  K. Krogfelt,et al.  Direct evidence that the FimH protein is the mannose-specific adhesin of Escherichia coli type 1 fimbriae , 1990, Infection and immunity.

[17]  B. McCormick,et al.  Type 1 pili are not necessary for colonization of the streptomycin-treated mouse large intestine by type 1-piliated Escherichia coli F-18 and E. coli K-12 , 1989, Infection and immunity.

[18]  M. Hanson,et al.  Identification and characterization of E. coli type-1 pilus tip adhesion protein , 1988, Nature.

[19]  N. Sharon,et al.  Lectinophagocytosis: a molecular mechanism of recognition between cell surface sugars and lectins in the phagocytosis of bacteria , 1988, Infection and immunity.

[20]  N. Sharon.  Bacterial lectins, cell‐cell recognition and infectious disease , 1987, FEBS letters.

[21]  N. Firon,et al.  Aromatic alpha-glycosides of mannose are powerful inhibitors of the adherence of type 1 fimbriated Escherichia coli to yeast and intestinal epithelial cells , 1987, Infection and immunity.

[22]  A. Schaeffer,et al.  Relationship of type 1 pilus expression in Escherichia coli to ascending urinary tract infections in mice , 1987, Infection and immunity.

[23]  A. Schaeffer,et al.  Regulation of production of type 1 pili among urinary tract isolates of Escherichia coli , 1986, Infection and Immunity.

[24]  L. Maurer,et al.  Receptor-binding function of type 1 pili effects bladder colonization by a clinical isolate of Escherichia coli , 1986, Infection and immunity.

[25]  G. Collingridge,et al.  Frequency-dependent involvement of NMDA receptors in the hippocampus: a novel synaptic mechanism , 1986, Nature.

[26]  B. Koellreutter,et al.  Oligomannoside-type glycopeptides inhibiting adhesion of Escherichia coli strains mediated by type 1 pili: preparation of potent inhibitors from plant glycoproteins , 1986, Infection and immunity.

[27]  Oakley Jd,et al.  Trypsin-susceptible cell surface characteristics of Streptococcus sanguis. , 1985 .

[28]  E. Boedeker,et al.  Functional heterogeneity of intestinal Escherichia coli strains expressing type 1 somatic pili (fimbriae): assessment of bacterial adherence to intestinal membranes and surface hydrophobicity , 1985, Infection and immunity.

[29]  W. Simpson,et al.  Protection against Escherichia coli-induced urinary tract infections with hybridoma antibodies directed against type 1 fimbriae or complementary D-mannose receptors , 1985, Infection and immunity.

[30]  Y. Abe,et al.  Role of type 1 fimbriae in the pathogenesis of ascending urinary tract infection induced by escherichia coli in mice , 1983, Infection and immunity.

[31]  L. Hagberg,et al.  Adhesion, hemagglutination, and virulence of Escherichia coli causing urinary tract infections , 1981, Infection and immunity.

[32]  F. Silverblatt,et al.  Antipili antibody affords protection against experimental ascending pyelonephritis. , 1979, The Journal of clinical investigation.

[33]  N. Sharon,et al.  Prevention of colonization of the urinary tract of mice with Escherichia coli by blocking of bacterial adherence with methyl alpha-D-mannopyranoside. , 1979, The Journal of infectious diseases.

[34]  N. Sharon,et al.  Adherence of Escherichia coli to human mucosal cells mediated by mannose receptors , 1977, Nature.

[35]  C. Brinton.  The structure, function, synthesis and genetic control of bacterial pili and a molecular model for DNA and RNA transport in gram negative bacteria. , 1965, Transactions of the New York Academy of Sciences.

[36]  I. Smith,et al.  Non-flagellar filamentous appendages (fimbriae) and haemagglutinating activity in Bacterium coli. , 1955, The Journal of pathology and bacteriology.

[37]  H. Mobley,et al.  Urinary tract infections : molecular pathogenesis and clinical management , 1996 .

[38]  D. Hasty,et al.  [41] Bacterial adhesion measured by growth of adherent organisms , 1995 .

[39]  C. Ballou.  Structure and biosynthesis of the mannan component of the yeast cell envelope. , 1976, Advances in microbial physiology.